相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Collapse of the CD27+B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers
Erica L. Carpenter et al.
CLINICAL CANCER RESEARCH (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: A Novel Therapeutic Target
Jennifer S. Ko et al.
CURRENT ONCOLOGY REPORTS (2009)
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4(+)CD25(+) regulatory T cells
Elena Degl'Innocenti et al.
CANCER RESEARCH (2008)
Enhanced functionality of CD4+CD25highFoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer
Junko Yokokawa et al.
CLINICAL CANCER RESEARCH (2008)
Paradigm shifts in cancer vaccine therapy
Jeffrey Schlom et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Myeloid-derived suppressor cells in inflammatory bowel disease:: A new immunoregulatory pathway
Lydia A. Haile et al.
GASTROENTEROLOGY (2008)
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages
Machteld M. Tiemessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer
Yukiko Kiniwa et al.
CLINICAL CANCER RESEARCH (2007)
Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients
Hitoe Torisu-Itakura et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Immunotherapy with dendritic cells for prostate cancer
Anna-Katharina Thomas-Kaskel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Human CD4+regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells
Dennis J. Hartigan-O'Connor et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer
Jeanny B. Aragon-Ching et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications
Juan Jose Corrales et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2007)
Characterization of circulating blood dendritic cell subsets DCI23+ (lymphoid) and DCIIC+ (myeloid) in prostate adenocarcinoma patients
Alessandro Sciarra et al.
PROSTATE (2007)
Exploiting regulatory T-cell populations for the immunotherapy of cancer
Hans J. J. van der Vliet et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
Siqing Wang et al.
BLOOD (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells
LS Taams et al.
HUMAN IMMUNOLOGY (2005)
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
CG Drake et al.
CANCER CELL (2005)
Plasma levels of transforming growth factor-1β and α2-macroglobulin before and after radical prostatectomy:: Association to clinicopathological parameters
O Sinnreich et al.
PROSTATE (2004)
Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients
S Ugurel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock
Y Le Tulzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance
K Wolk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Immature myeloid cells and cancer-associated immune suppression
S Kusmartsev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells
AB Dietz et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Cytokine variations in patients with hormone treated prostate cancer
GJ Wise et al.
JOURNAL OF UROLOGY (2000)
分享论文
